Brain Cancer
News and reporting on brain cancer.
Avistone Biotechnology to Launch Phase I Trial of c-MET Inhibitor in Canada
Canadian health authorities cleared the firm's application to study ANS01 as treatment for advanced solid tumor patients harboring various MET alterations.
The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research validates findings from this small study.
Telix Seeks Approval of PET Imaging Agent Pixclara to Track Brain Cancer Treatment
Pixclara has potential as a companion diagnostic for Telix's LAT1-targeted radiopharmaceutical agent TLX101 in glioblastoma.
Diakonos Oncology Closes Oversubscribed $11.4M Seed Financing Round
The investment will fund operations through late 2025, including a readout from a Phase I trial of the firm's personalized cancer vaccine in glioblastoma.
Pathos AI Acquires PRMT5 Inhibitor From Prelude Therapeutics
Pathos plans to use its AI platform to develop a new biomarker strategy for the compound to boost response rates.
Feb 23, 2024
Jan 24, 2024
Dec 19, 2023
Nov 17, 2023